Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial.

Saved in:
Bibliographic Details
Title: Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial.
Authors: Al-Samkari H; Mass General Brigham Cancer Institute, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Shatzel JJ; Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Panch SR; Fred Hutch Cancer Center, University of Washington, Seattle, WA., Keating JH; Dana-Farber Cancer Institute, Boston, MA., Walsh EP; Mass General Brigham Cancer Institute, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Weekes CD; Mass General Brigham Cancer Institute, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Kardosh A; Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Cohen SA; Fred Hutch Cancer Center, University of Washington, Seattle, WA., Cohen JJ; University of Miami Health System/Sylvester Comprehensive Cancer Center, Miami, FL., Hodges PG; Mass General Brigham Cancer Institute, Massachusetts General Hospital, Boston, MA., Dhaver SE; Mass General Brigham Cancer Institute, Massachusetts General Hospital, Boston, MA., Strojny N; Mass General Brigham Cancer Institute, Massachusetts General Hospital, Boston, MA., Donovan C; Mass General Brigham Cancer Institute, Massachusetts General Hospital, Boston, MA., Belibasakis C; Mass General Brigham Cancer Institute, Massachusetts General Hospital, Boston, MA., Soff GA; University of Miami Health System/Sylvester Comprehensive Cancer Center, Miami, FL.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Jul 13, pp. JCO2600568. Date of Electronic Publication: 2026 Jul 13.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO-26-00568